Ruxolitinib phosphate is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

Natasha Benn shares family's fight with rare cancer, while geneticists discuss breakthroughs in cancer research ...

Excited about the Greek ­holiday she and her daughter were about to embark on, Deborah King's thoughts were fixed on ...

Bone cancer is when cells in your bones grow out of control. Usually, when you have bone cancer, it comes from another cancer that has spread to your bones or metastatic bone cancer. But ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

In men, the most common type of breast cancer is ductal carcinoma, which develops in the breast ducts. Men can also get lobular carcinoma, which forms in the lobules, but this accounts for only around ...

It typically originates in the milk-producing ducts (ductal carcinoma) or the lobules (lobular carcinoma), which are the glands that produce milk. Breast cancer can affect both women and ...

Endocrine therapy: hormone therapy that either adds, blocks or removes hormones to treat cancer. Recurrence: return of cancer after treatment. Lobular breast cancer: cancer that starts in the ...

It wasn’t until 2022 she finally received a mammogram and was diagnosed with stage 3 invasive lobular carcinoma, a rare and slow-growing form of breast cancer that starts in the milk-producing ...

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to ...